Clinical Trial Update: Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell Injections on MoUth Fibrosis and Handicap in Patients With Systemic sclEroderma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic cultured adipose-derived mesenchymal stromal cell injections for mouth fibrosis and handicap in systemic sclerosis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Allogeneic cultured adipose-derived mesenchymal stromal cells (adipose-derived mesenchymal stromal cells)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Systemic Scleroderma | Phase 2 | Status: NOT_YET_RECRUITING